HEADER HYDROLASE 11-JUN-07 2Q8U TITLE CRYSTAL STRUCTURE OF MRE11 FROM THERMOTOGA MARITIMA MSB8 (TM1635) AT TITLE 2 2.20 A RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: EXONUCLEASE, PUTATIVE; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: RESIDUES 1-324; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: THERMOTOGA MARITIMA MSB8; SOURCE 3 ORGANISM_TAXID: 243274; SOURCE 4 STRAIN: MSB8, DSM 3109, JCM 10099; SOURCE 5 ATCC: 43589; SOURCE 6 GENE: TM_1635; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: HK100; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: SPEEDET KEYWDS STRUCTURAL GENOMICS, JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, KEYWDS 2 PROTEIN STRUCTURE INITIATIVE, PSI-2, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) REVDAT 9 25-JAN-23 2Q8U 1 SEQADV REVDAT 8 24-JUL-19 2Q8U 1 REMARK LINK REVDAT 7 25-OCT-17 2Q8U 1 REMARK REVDAT 6 18-OCT-17 2Q8U 1 REMARK REVDAT 5 13-JUL-11 2Q8U 1 VERSN REVDAT 4 28-JUL-10 2Q8U 1 HEADER TITLE KEYWDS REVDAT 3 07-APR-10 2Q8U 1 JRNL REVDAT 2 24-FEB-09 2Q8U 1 VERSN REVDAT 1 26-JUN-07 2Q8U 0 JRNL AUTH D.DAS,D.MOIANI,H.L.AXELROD,M.D.MILLER,D.MCMULLAN,K.K.JIN, JRNL AUTH 2 P.ABDUBEK,T.ASTAKHOVA,P.BURRA,D.CARLTON,H.J.CHIU,T.CLAYTON, JRNL AUTH 3 M.C.DELLER,L.DUAN,D.ERNST,J.FEUERHELM,J.C.GRANT,A.GRZECHNIK, JRNL AUTH 4 S.K.GRZECHNIK,G.W.HAN,L.JAROSZEWSKI,H.E.KLOCK,M.W.KNUTH, JRNL AUTH 5 P.KOZBIAL,S.S.KRISHNA,A.KUMAR,D.MARCIANO,A.T.MORSE, JRNL AUTH 6 E.NIGOGHOSSIAN,L.OKACH,J.PAULSEN,R.REYES,C.L.RIFE, JRNL AUTH 7 N.SEFCOVIC,H.J.TIEN,C.B.TRAME,H.VAN DEN BEDEM,D.WEEKES,Q.XU, JRNL AUTH 8 K.O.HODGSON,J.WOOLEY,M.A.ELSLIGER,A.M.DEACON,A.GODZIK, JRNL AUTH 9 S.A.LESLEY,J.A.TAINER,I.A.WILSON JRNL TITL CRYSTAL STRUCTURE OF THE FIRST EUBACTERIAL MRE11 NUCLEASE JRNL TITL 2 REVEALS NOVEL FEATURES THAT MAY DISCRIMINATE SUBSTRATES JRNL TITL 3 DURING DNA REPAIR. JRNL REF J.MOL.BIOL. V. 397 647 2010 JRNL REFN ISSN 0022-2836 JRNL PMID 20122942 JRNL DOI 10.1016/J.JMB.2010.01.049 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD WITH PHASES REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 37.45 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.7 REMARK 3 NUMBER OF REFLECTIONS : 42148 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.200 REMARK 3 R VALUE (WORKING SET) : 0.198 REMARK 3 FREE R VALUE : 0.241 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2120 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.20 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.26 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2970 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.30 REMARK 3 BIN R VALUE (WORKING SET) : 0.2720 REMARK 3 BIN FREE R VALUE SET COUNT : 156 REMARK 3 BIN FREE R VALUE : 0.3710 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4778 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 159 REMARK 3 REMARK 3 B VALUES. REMARK 3 B VALUE TYPE : LIKELY RESIDUAL REMARK 3 FROM WILSON PLOT (A**2) : 43.03 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 41.95 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -2.12000 REMARK 3 B22 (A**2) : 2.73000 REMARK 3 B33 (A**2) : -0.41000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.50000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.223 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.191 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.162 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 12.776 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.959 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.939 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4978 ; 0.016 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 3452 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 6756 ; 1.428 ; 1.977 REMARK 3 BOND ANGLES OTHERS (DEGREES): 8417 ; 0.817 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 620 ; 6.673 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 222 ;34.069 ;23.423 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 877 ;15.898 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 34 ;19.627 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 769 ; 0.065 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 5450 ; 0.015 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 1024 ; 0.002 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 896 ; 0.233 ; 0.300 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 3526 ; 0.218 ; 0.300 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 2373 ; 0.191 ; 0.500 REMARK 3 NON-BONDED TORSION OTHERS (A): 2724 ; 0.093 ; 0.500 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 350 ; 0.214 ; 0.500 REMARK 3 H-BOND (X...Y) OTHERS (A): 3 ; 0.135 ; 0.500 REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 12 ; 0.076 ; 0.300 REMARK 3 SYMMETRY VDW OTHERS (A): 29 ; 0.315 ; 0.300 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 8 ; 0.192 ; 0.500 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3120 ; 4.038 ; 3.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1215 ; 1.477 ; 3.000 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4950 ; 5.283 ; 5.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2073 ; 8.361 ; 8.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1792 ;10.128 ;11.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : 1 REMARK 3 REMARK 3 NCS GROUP NUMBER : 1 REMARK 3 CHAIN NAMES : A B REMARK 3 NUMBER OF COMPONENTS NCS GROUP : 10 REMARK 3 COMPONENT C SSSEQI TO C SSSEQI CODE REMARK 3 1 A 4 A 7 4 REMARK 3 1 B 7 B 7 4 REMARK 3 2 A 8 A 9 4 REMARK 3 2 B 8 B 9 4 REMARK 3 3 A 10 A 110 4 REMARK 3 3 B 10 B 110 4 REMARK 3 4 A 111 A 112 4 REMARK 3 4 B 111 B 112 4 REMARK 3 5 A 113 A 118 4 REMARK 3 5 B 113 B 118 4 REMARK 3 6 A 119 A 120 4 REMARK 3 6 B 119 B 120 4 REMARK 3 7 A 121 A 245 4 REMARK 3 7 B 121 B 245 4 REMARK 3 8 A 246 A 247 4 REMARK 3 8 B 246 B 247 4 REMARK 3 9 A 248 A 263 4 REMARK 3 9 B 248 B 263 4 REMARK 3 10 A 264 A 324 4 REMARK 3 10 B 264 B 324 4 REMARK 3 GROUP CHAIN COUNT RMS WEIGHT REMARK 3 MEDIUM POSITIONAL 1 A (A): 3827 ; 0.550 ; 0.500 REMARK 3 MEDIUM THERMAL 1 A (A**2): 3827 ; 2.200 ; 2.000 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 4 A 324 REMARK 3 ORIGIN FOR THE GROUP (A): -17.3458 -96.0634 -0.9736 REMARK 3 T TENSOR REMARK 3 T11: -0.1836 T22: -0.0852 REMARK 3 T33: -0.1126 T12: -0.0319 REMARK 3 T13: 0.0111 T23: -0.0764 REMARK 3 L TENSOR REMARK 3 L11: 1.3086 L22: 2.1290 REMARK 3 L33: 1.0992 L12: -0.5382 REMARK 3 L13: 0.2546 L23: -0.8904 REMARK 3 S TENSOR REMARK 3 S11: 0.0637 S12: -0.0243 S13: 0.1240 REMARK 3 S21: -0.1556 S22: -0.1071 S23: -0.0102 REMARK 3 S31: 0.0457 S32: 0.0823 S33: 0.0434 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 7 B 324 REMARK 3 ORIGIN FOR THE GROUP (A): -32.3899-100.4689 41.2857 REMARK 3 T TENSOR REMARK 3 T11: -0.1081 T22: -0.0723 REMARK 3 T33: -0.0711 T12: -0.0381 REMARK 3 T13: 0.0120 T23: 0.0449 REMARK 3 L TENSOR REMARK 3 L11: 2.3936 L22: 1.7294 REMARK 3 L33: 5.5388 L12: 0.4871 REMARK 3 L13: 0.7569 L23: 2.2421 REMARK 3 S TENSOR REMARK 3 S11: 0.0665 S12: 0.1495 S13: 0.0055 REMARK 3 S21: 0.0966 S22: -0.1778 S23: 0.0897 REMARK 3 S31: 0.2534 S32: -0.6720 S33: 0.1113 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 1. HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS. REMARK 3 2. A MET-INHIBITION PROTOCOL WAS USED FOR SELENOMETHIONINE REMARK 3 INCORPORATION DURING PROTEIN EXPRESSION. THE OCCUPANCY REMARK 3 OF THE SE ATOMS IN THE MSE RESIDUES WAS REDUCED TO REMARK 3 0.75 TO ACCOUNT FOR THE REDUCED SCATTERING POWER DUE TO REMARK 3 PARTIAL S-MET INCORPORATION. REMARK 3 3. ATOM RECORD CONTAINS RESIDUAL B FACTORS ONLY. REMARK 3 4. RESIDUES A93-A98, A141-A147, A188-A195, B95-B98, B141-B149, REMARK 3 B187-B195, B311-B312 ARE DISORDERED AND ARE NOT MODELED. REMARK 3 5. THE STRUCTURE FACTOR AMPLITUDES USED IN THE FINAL REMARK 3 REFINEMENT WERE FROM A NATIVE CRYSTAL. THE REFINEMENT OF THE REMARK 3 COORDINATES WAS RESTRAINED WITH THE EXPERIMENTAL PHASES FROM A REMARK 3 CRYSTAL OF THE SELENOMETHIONINE-SUBSTITUTED PROTEIN THAT WAS REMARK 3 USED FOR INITIAL PHASE DETERMINATION BY MULTIPLE WAVELENGTH REMARK 3 ANOMALOUS DISPERSION. REMARK 4 REMARK 4 2Q8U COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 12-JUN-07. REMARK 100 THE DEPOSITION ID IS D_1000043294. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 13-MAY-07; NULL REMARK 200 TEMPERATURE (KELVIN) : 100; NULL REMARK 200 PH : 5.57; 5.14 REMARK 200 NUMBER OF CRYSTALS USED : 2 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y; Y REMARK 200 RADIATION SOURCE : SSRL; SSRL REMARK 200 BEAMLINE : BL11-1; BL11-1 REMARK 200 X-RAY GENERATOR MODEL : NULL; NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M; NULL REMARK 200 WAVELENGTH OR RANGE (A) : 0.98086; 0.91837, 0.97917, REMARK 200 0.97891 REMARK 200 MONOCHROMATOR : SINGLE CRYSTAL SI(111) BENT REMARK 200 (HORIZONTAL FOCUSING); NULL REMARK 200 OPTICS : FLAT MIRROR (VERTICAL FOCUSING); REMARK 200 NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD; NULL REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 325 MM CCD; NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 56132 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 37.450 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.8 REMARK 200 DATA REDUNDANCY : 2.600 REMARK 200 R MERGE (I) : 0.04300 REMARK 200 R SYM (I) : 0.04300 REMARK 200 FOR THE DATA SET : 11.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.26 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.5 REMARK 200 DATA REDUNDANCY IN SHELL : 2.50 REMARK 200 R MERGE FOR SHELL (I) : 0.53300 REMARK 200 R SYM FOR SHELL (I) : 0.53300 REMARK 200 FOR SHELL : 0.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: MAD; NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: SHELX, SHELXD, AUTOSHARP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: TWO CRYSTALS WERE USED FOR THE SOLUTION OF THIS STRUCTURE. REMARK 200 A 2.4 ANGSTROM MAD DATA COLLECTED FROM ONE CRYSTAL WAS USED TO REMARK 200 PHASE AND TRACE AN INITIAL MODEL. THE MODEL WAS THEN REFINED REMARK 200 USING THE AMPLITUDES FROM A SECOND CRYSTAL THAT DIFFRACTED TO AN REMARK 200 ENHANCED RESOLUTION OF 2.2 ANGSTROM. THE 2.4 ANGSTROM MAD PHASES REMARK 200 FROM THE FIRST CRYSTAL WERE USED AS PHASE RESTRAINTS DURING THE REMARK 200 REFINEMENT. REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 55.29 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.75 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NANODROP, 10.3% PEG 6000, 0.1M MES PH REMARK 280 5.57, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K. NANODROP, REMARK 280 2.5% PEG 6000, 0.1M MES PH 5.14, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 56.70700 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 THIS ENTRY CONTAINS THE CRYSTALLOGRAPHIC ASYMMETRIC UNIT REMARK 300 WHICH CONSISTS OF 2 CHAINS. SEE REMARK 350 FOR REMARK 300 INFORMATION ON GENERATING THE BIOLOGICAL MOLECULE(S). REMARK 300 SIZE EXCLUSION CHROMATOGRAPHY SUGGESTS THE ASSIGNMENT OF A REMARK 300 MONOMER AS THE SIGNIFICANT OLIGOMERIZATION STATE. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1580 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 28020 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -23.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MSE A -11 REMARK 465 GLY A -10 REMARK 465 SER A -9 REMARK 465 ASP A -8 REMARK 465 LYS A -7 REMARK 465 ILE A -6 REMARK 465 HIS A -5 REMARK 465 ASN A 93 REMARK 465 HIS A 94 REMARK 465 ASP A 95 REMARK 465 TRP A 96 REMARK 465 LYS A 97 REMARK 465 GLY A 98 REMARK 465 ASP A 141 REMARK 465 GLU A 142 REMARK 465 SER A 143 REMARK 465 GLU A 144 REMARK 465 ALA A 145 REMARK 465 LEU A 146 REMARK 465 ARG A 147 REMARK 465 GLY A 188 REMARK 465 TYR A 189 REMARK 465 ALA A 190 REMARK 465 GLY A 191 REMARK 465 ILE A 192 REMARK 465 GLU A 193 REMARK 465 GLN A 194 REMARK 465 GLY A 195 REMARK 465 MSE B -11 REMARK 465 GLY B -10 REMARK 465 SER B -9 REMARK 465 ASP B -8 REMARK 465 LYS B -7 REMARK 465 ILE B -6 REMARK 465 HIS B -5 REMARK 465 HIS B -4 REMARK 465 HIS B -3 REMARK 465 HIS B -2 REMARK 465 HIS B -1 REMARK 465 HIS B 0 REMARK 465 VAL B 1 REMARK 465 ILE B 2 REMARK 465 ASN B 3 REMARK 465 LEU B 4 REMARK 465 LYS B 5 REMARK 465 GLU B 6 REMARK 465 ASP B 95 REMARK 465 TRP B 96 REMARK 465 LYS B 97 REMARK 465 GLY B 98 REMARK 465 ASP B 141 REMARK 465 GLU B 142 REMARK 465 SER B 143 REMARK 465 GLU B 144 REMARK 465 ALA B 145 REMARK 465 LEU B 146 REMARK 465 ARG B 147 REMARK 465 LYS B 148 REMARK 465 ASN B 149 REMARK 465 ALA B 187 REMARK 465 GLY B 188 REMARK 465 TYR B 189 REMARK 465 ALA B 190 REMARK 465 GLY B 191 REMARK 465 ILE B 192 REMARK 465 GLU B 193 REMARK 465 GLN B 194 REMARK 465 GLY B 195 REMARK 465 PRO B 311 REMARK 465 ASP B 312 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 HIS A -4 ND1 CD2 CE1 NE2 REMARK 470 LYS A 5 CG CD CE NZ REMARK 470 GLU A 43 CD OE1 OE2 REMARK 470 ARG A 63 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 100 CG CD CE NZ REMARK 470 LYS A 131 CE NZ REMARK 470 ARG A 154 CZ NH1 NH2 REMARK 470 ARG A 196 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 255 CD CE NZ REMARK 470 LYS A 278 NZ REMARK 470 LYS A 279 NZ REMARK 470 LYS B 47 CE NZ REMARK 470 ARG B 63 CG CD NE CZ NH1 NH2 REMARK 470 LEU B 99 CG CD1 CD2 REMARK 470 LYS B 100 CE NZ REMARK 470 LYS B 127 CE NZ REMARK 470 LYS B 131 CE NZ REMARK 470 TYR B 139 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 ASP B 152 CG OD1 OD2 REMARK 470 ARG B 154 CD NE CZ NH1 NH2 REMARK 470 LYS B 170 CG CD CE NZ REMARK 470 GLU B 172 CG CD OE1 OE2 REMARK 470 ARG B 196 CD NE CZ NH1 NH2 REMARK 470 GLU B 197 CD OE1 OE2 REMARK 470 ARG B 202 CZ NH1 NH2 REMARK 470 GLN B 226 CG CD OE1 NE2 REMARK 470 GLU B 246 CD OE1 OE2 REMARK 470 LYS B 255 CD CE NZ REMARK 470 ARG B 256 CZ NH1 NH2 REMARK 470 LYS B 278 NZ REMARK 470 LYS B 279 NZ REMARK 470 ARG B 293 CZ NH1 NH2 REMARK 470 GLU B 316 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLU B 158 C SER B 159 N 0.162 REMARK 500 ARG B 160 C ARG B 160 O 0.119 REMARK 500 ASN B 162 C ASN B 162 O 0.219 REMARK 500 SER B 207 C SER B 207 O 0.121 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 237 NE - CZ - NH2 ANGL. DEV. = -3.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 25 -54.84 -130.06 REMARK 500 ASN A 149 178.87 79.88 REMARK 500 GLU A 150 -53.22 -153.91 REMARK 500 ASP A 173 -89.00 -113.77 REMARK 500 HIS A 216 -20.06 111.41 REMARK 500 ARG A 293 -63.73 -29.90 REMARK 500 ASN B 93 -159.69 -70.57 REMARK 500 LYS B 170 32.80 -86.82 REMARK 500 GLU B 172 -83.86 -102.91 REMARK 500 ASP B 173 -63.91 -99.64 REMARK 500 HIS B 216 -17.57 116.88 REMARK 500 SER B 268 69.33 32.08 REMARK 500 SER B 268 67.16 34.69 REMARK 500 PRO B 296 40.12 -86.98 REMARK 500 GLU B 304 -63.06 -100.44 REMARK 500 MSE B 314 -67.07 33.37 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 ILE A 323 GLU A 324 141.49 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 283492 RELATED DB: TARGETDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 THIS CONSTRUCT IS COMPRISED OF AMINO ACIDS 1-324 OF THE REMARK 999 FULL-LENGTH PROTEIN (1-385) AND WAS EXPRESSED WITH A REMARK 999 PURIFICATION TAG MGSDKIHHHHHH. DNA SEQUENCING INDICATES REMARK 999 THAT RESIDUE 1 IS VALINE (NOT MET) IN THE CLONED CONSTRUCT. REMARK 999 THE SEQUENCING RESULTS ARE CONSISTENT WITH THE ELECTRON REMARK 999 DENSITY AND MASS SPECTROMETRY RESULTS FOR THE EXPRESSED REMARK 999 PROTEIN. DBREF 2Q8U A 1 324 UNP Q9X1X0 Q9X1X0_THEMA 1 324 DBREF 2Q8U B 1 324 UNP Q9X1X0 Q9X1X0_THEMA 1 324 SEQADV 2Q8U MSE A -11 UNP Q9X1X0 EXPRESSION TAG SEQADV 2Q8U GLY A -10 UNP Q9X1X0 EXPRESSION TAG SEQADV 2Q8U SER A -9 UNP Q9X1X0 EXPRESSION TAG SEQADV 2Q8U ASP A -8 UNP Q9X1X0 EXPRESSION TAG SEQADV 2Q8U LYS A -7 UNP Q9X1X0 EXPRESSION TAG SEQADV 2Q8U ILE A -6 UNP Q9X1X0 EXPRESSION TAG SEQADV 2Q8U HIS A -5 UNP Q9X1X0 EXPRESSION TAG SEQADV 2Q8U HIS A -4 UNP Q9X1X0 EXPRESSION TAG SEQADV 2Q8U HIS A -3 UNP Q9X1X0 EXPRESSION TAG SEQADV 2Q8U HIS A -2 UNP Q9X1X0 EXPRESSION TAG SEQADV 2Q8U HIS A -1 UNP Q9X1X0 EXPRESSION TAG SEQADV 2Q8U HIS A 0 UNP Q9X1X0 EXPRESSION TAG SEQADV 2Q8U VAL A 1 UNP Q9X1X0 MET 1 SEE REMARK 999 SEQADV 2Q8U MSE A 81 UNP Q9X1X0 MET 81 MODIFIED RESIDUE SEQADV 2Q8U MSE A 82 UNP Q9X1X0 MET 82 MODIFIED RESIDUE SEQADV 2Q8U MSE A 117 UNP Q9X1X0 MET 117 MODIFIED RESIDUE SEQADV 2Q8U MSE A 178 UNP Q9X1X0 MET 178 MODIFIED RESIDUE SEQADV 2Q8U MSE A 314 UNP Q9X1X0 MET 314 MODIFIED RESIDUE SEQADV 2Q8U MSE B -11 UNP Q9X1X0 EXPRESSION TAG SEQADV 2Q8U GLY B -10 UNP Q9X1X0 EXPRESSION TAG SEQADV 2Q8U SER B -9 UNP Q9X1X0 EXPRESSION TAG SEQADV 2Q8U ASP B -8 UNP Q9X1X0 EXPRESSION TAG SEQADV 2Q8U LYS B -7 UNP Q9X1X0 EXPRESSION TAG SEQADV 2Q8U ILE B -6 UNP Q9X1X0 EXPRESSION TAG SEQADV 2Q8U HIS B -5 UNP Q9X1X0 EXPRESSION TAG SEQADV 2Q8U HIS B -4 UNP Q9X1X0 EXPRESSION TAG SEQADV 2Q8U HIS B -3 UNP Q9X1X0 EXPRESSION TAG SEQADV 2Q8U HIS B -2 UNP Q9X1X0 EXPRESSION TAG SEQADV 2Q8U HIS B -1 UNP Q9X1X0 EXPRESSION TAG SEQADV 2Q8U HIS B 0 UNP Q9X1X0 EXPRESSION TAG SEQADV 2Q8U VAL B 1 UNP Q9X1X0 MET 1 SEE REMARK 999 SEQADV 2Q8U MSE B 81 UNP Q9X1X0 MET 81 MODIFIED RESIDUE SEQADV 2Q8U MSE B 82 UNP Q9X1X0 MET 82 MODIFIED RESIDUE SEQADV 2Q8U MSE B 117 UNP Q9X1X0 MET 117 MODIFIED RESIDUE SEQADV 2Q8U MSE B 178 UNP Q9X1X0 MET 178 MODIFIED RESIDUE SEQADV 2Q8U MSE B 314 UNP Q9X1X0 MET 314 MODIFIED RESIDUE SEQRES 1 A 336 MSE GLY SER ASP LYS ILE HIS HIS HIS HIS HIS HIS VAL SEQRES 2 A 336 ILE ASN LEU LYS GLU LEU LYS ILE LEU HIS THR SER ASP SEQRES 3 A 336 TRP HIS LEU GLY VAL THR SER TRP THR SER SER ARG PRO SEQRES 4 A 336 VAL ASP ARG ARG GLU GLU LEU LYS LYS ALA LEU ASP LYS SEQRES 5 A 336 VAL VAL GLU GLU ALA GLU LYS ARG GLU VAL ASP LEU ILE SEQRES 6 A 336 LEU LEU THR GLY ASP LEU LEU HIS SER ARG ASN ASN PRO SEQRES 7 A 336 SER VAL VAL ALA LEU HIS ASP LEU LEU ASP TYR LEU LYS SEQRES 8 A 336 ARG MSE MSE ARG THR ALA PRO VAL VAL VAL LEU PRO GLY SEQRES 9 A 336 ASN HIS ASP TRP LYS GLY LEU LYS LEU PHE GLY ASN PHE SEQRES 10 A 336 VAL THR SER ILE SER SER ASP ILE THR PHE VAL MSE SER SEQRES 11 A 336 PHE GLU PRO VAL ASP VAL GLU ALA LYS ARG GLY GLN LYS SEQRES 12 A 336 VAL ARG ILE LEU PRO PHE PRO TYR PRO ASP GLU SER GLU SEQRES 13 A 336 ALA LEU ARG LYS ASN GLU GLY ASP PHE ARG PHE PHE LEU SEQRES 14 A 336 GLU SER ARG LEU ASN LYS LEU TYR GLU GLU ALA LEU LYS SEQRES 15 A 336 LYS GLU ASP PHE ALA ILE PHE MSE GLY HIS PHE THR VAL SEQRES 16 A 336 GLU GLY LEU ALA GLY TYR ALA GLY ILE GLU GLN GLY ARG SEQRES 17 A 336 GLU ILE ILE ILE ASN ARG ALA LEU ILE PRO SER VAL VAL SEQRES 18 A 336 ASP TYR ALA ALA LEU GLY HIS ILE HIS SER PHE ARG GLU SEQRES 19 A 336 ILE GLN LYS GLN PRO LEU THR ILE TYR PRO GLY SER LEU SEQRES 20 A 336 ILE ARG ILE ASP PHE GLY GLU GLU ALA ASP GLU LYS GLY SEQRES 21 A 336 ALA VAL PHE VAL GLU LEU LYS ARG GLY GLU PRO PRO ARG SEQRES 22 A 336 TYR GLU ARG ILE ASP ALA SER PRO LEU PRO LEU LYS THR SEQRES 23 A 336 LEU TYR TYR LYS LYS ILE ASP THR SER ALA LEU LYS SER SEQRES 24 A 336 ILE ARG ASP PHE CYS ARG ASN PHE PRO GLY TYR VAL ARG SEQRES 25 A 336 VAL VAL TYR GLU GLU ASP SER GLY ILE LEU PRO ASP LEU SEQRES 26 A 336 MSE GLY GLU ILE ASP ASN LEU VAL LYS ILE GLU SEQRES 1 B 336 MSE GLY SER ASP LYS ILE HIS HIS HIS HIS HIS HIS VAL SEQRES 2 B 336 ILE ASN LEU LYS GLU LEU LYS ILE LEU HIS THR SER ASP SEQRES 3 B 336 TRP HIS LEU GLY VAL THR SER TRP THR SER SER ARG PRO SEQRES 4 B 336 VAL ASP ARG ARG GLU GLU LEU LYS LYS ALA LEU ASP LYS SEQRES 5 B 336 VAL VAL GLU GLU ALA GLU LYS ARG GLU VAL ASP LEU ILE SEQRES 6 B 336 LEU LEU THR GLY ASP LEU LEU HIS SER ARG ASN ASN PRO SEQRES 7 B 336 SER VAL VAL ALA LEU HIS ASP LEU LEU ASP TYR LEU LYS SEQRES 8 B 336 ARG MSE MSE ARG THR ALA PRO VAL VAL VAL LEU PRO GLY SEQRES 9 B 336 ASN HIS ASP TRP LYS GLY LEU LYS LEU PHE GLY ASN PHE SEQRES 10 B 336 VAL THR SER ILE SER SER ASP ILE THR PHE VAL MSE SER SEQRES 11 B 336 PHE GLU PRO VAL ASP VAL GLU ALA LYS ARG GLY GLN LYS SEQRES 12 B 336 VAL ARG ILE LEU PRO PHE PRO TYR PRO ASP GLU SER GLU SEQRES 13 B 336 ALA LEU ARG LYS ASN GLU GLY ASP PHE ARG PHE PHE LEU SEQRES 14 B 336 GLU SER ARG LEU ASN LYS LEU TYR GLU GLU ALA LEU LYS SEQRES 15 B 336 LYS GLU ASP PHE ALA ILE PHE MSE GLY HIS PHE THR VAL SEQRES 16 B 336 GLU GLY LEU ALA GLY TYR ALA GLY ILE GLU GLN GLY ARG SEQRES 17 B 336 GLU ILE ILE ILE ASN ARG ALA LEU ILE PRO SER VAL VAL SEQRES 18 B 336 ASP TYR ALA ALA LEU GLY HIS ILE HIS SER PHE ARG GLU SEQRES 19 B 336 ILE GLN LYS GLN PRO LEU THR ILE TYR PRO GLY SER LEU SEQRES 20 B 336 ILE ARG ILE ASP PHE GLY GLU GLU ALA ASP GLU LYS GLY SEQRES 21 B 336 ALA VAL PHE VAL GLU LEU LYS ARG GLY GLU PRO PRO ARG SEQRES 22 B 336 TYR GLU ARG ILE ASP ALA SER PRO LEU PRO LEU LYS THR SEQRES 23 B 336 LEU TYR TYR LYS LYS ILE ASP THR SER ALA LEU LYS SER SEQRES 24 B 336 ILE ARG ASP PHE CYS ARG ASN PHE PRO GLY TYR VAL ARG SEQRES 25 B 336 VAL VAL TYR GLU GLU ASP SER GLY ILE LEU PRO ASP LEU SEQRES 26 B 336 MSE GLY GLU ILE ASP ASN LEU VAL LYS ILE GLU MODRES 2Q8U MSE A 81 MET SELENOMETHIONINE MODRES 2Q8U MSE A 82 MET SELENOMETHIONINE MODRES 2Q8U MSE A 117 MET SELENOMETHIONINE MODRES 2Q8U MSE A 178 MET SELENOMETHIONINE MODRES 2Q8U MSE A 314 MET SELENOMETHIONINE MODRES 2Q8U MSE B 81 MET SELENOMETHIONINE MODRES 2Q8U MSE B 82 MET SELENOMETHIONINE MODRES 2Q8U MSE B 117 MET SELENOMETHIONINE MODRES 2Q8U MSE B 178 MET SELENOMETHIONINE MODRES 2Q8U MSE B 314 MET SELENOMETHIONINE HET MSE A 81 8 HET MSE A 82 8 HET MSE A 117 8 HET MSE A 178 8 HET MSE A 314 8 HET MSE B 81 13 HET MSE B 82 13 HET MSE B 117 8 HET MSE B 178 8 HET MSE B 314 8 HETNAM MSE SELENOMETHIONINE FORMUL 1 MSE 10(C5 H11 N O2 SE) FORMUL 3 HOH *159(H2 O) HELIX 1 1 ARG A 30 GLU A 49 1 20 HELIX 2 2 SER A 67 ALA A 85 1 19 HELIX 3 3 LEU A 99 SER A 110 1 12 HELIX 4 4 GLY A 151 LYS A 170 1 20 HELIX 5 5 ASN A 201 ILE A 205 5 5 HELIX 6 6 ASP A 239 GLU A 243 5 5 HELIX 7 7 ASP A 281 ASN A 294 1 14 HELIX 8 8 ASP A 312 ILE A 317 1 6 HELIX 9 9 ARG B 30 ARG B 48 1 19 HELIX 10 10 SER B 67 ALA B 85 1 19 HELIX 11 11 LEU B 99 SER B 110 1 12 HELIX 12 12 GLY B 151 LYS B 170 1 20 HELIX 13 13 ASN B 201 ILE B 205 5 5 HELIX 14 14 ASP B 239 GLU B 243 5 5 HELIX 15 15 ASP B 281 PHE B 295 1 15 SHEET 1 A 6 ILE A 113 PHE A 115 0 SHEET 2 A 6 VAL A 87 VAL A 89 1 N VAL A 89 O THR A 114 SHEET 3 A 6 LEU A 52 THR A 56 1 N ILE A 53 O VAL A 88 SHEET 4 A 6 GLU A 6 SER A 13 1 N LEU A 10 O LEU A 54 SHEET 5 A 6 GLY A 248 LYS A 255 -1 O VAL A 252 N ILE A 9 SHEET 6 A 6 ARG A 261 ASP A 266 -1 O GLU A 263 N PHE A 251 SHEET 1 B 2 THR A 20 SER A 21 0 SHEET 2 B 2 VAL A 28 ASP A 29 -1 O VAL A 28 N SER A 21 SHEET 1 C 6 VAL A 122 GLU A 125 0 SHEET 2 C 6 LYS A 131 PHE A 137 -1 O ILE A 134 N VAL A 122 SHEET 3 C 6 PHE A 174 HIS A 180 1 O ILE A 176 N LEU A 135 SHEET 4 C 6 TYR A 211 GLY A 215 1 O ALA A 213 N PHE A 177 SHEET 5 C 6 THR A 229 TYR A 231 1 O ILE A 230 N LEU A 214 SHEET 6 C 6 ARG A 221 GLN A 224 -1 N GLN A 224 O THR A 229 SHEET 1 D 2 THR A 182 VAL A 183 0 SHEET 2 D 2 ILE A 199 ILE A 200 1 O ILE A 200 N THR A 182 SHEET 1 E 3 LEU A 272 LYS A 279 0 SHEET 2 E 3 TYR A 298 GLU A 305 1 O ARG A 300 N LEU A 275 SHEET 3 E 3 LEU A 320 LYS A 322 1 O LYS A 322 N VAL A 301 SHEET 1 F 6 ILE B 113 PHE B 115 0 SHEET 2 F 6 VAL B 87 VAL B 89 1 N VAL B 89 O THR B 114 SHEET 3 F 6 LEU B 52 THR B 56 1 N ILE B 53 O VAL B 88 SHEET 4 F 6 LYS B 8 SER B 13 1 N LEU B 10 O LEU B 54 SHEET 5 F 6 GLY B 248 GLU B 253 -1 O VAL B 252 N ILE B 9 SHEET 6 F 6 ARG B 261 ASP B 266 -1 O ILE B 265 N ALA B 249 SHEET 1 G 2 THR B 20 SER B 21 0 SHEET 2 G 2 VAL B 28 ASP B 29 -1 O VAL B 28 N SER B 21 SHEET 1 H 6 VAL B 122 GLU B 125 0 SHEET 2 H 6 LYS B 131 PHE B 137 -1 O ILE B 134 N VAL B 122 SHEET 3 H 6 PHE B 174 HIS B 180 1 O PHE B 174 N ARG B 133 SHEET 4 H 6 TYR B 211 GLY B 215 1 O ALA B 213 N PHE B 177 SHEET 5 H 6 LEU B 228 TYR B 231 1 O LEU B 228 N ALA B 212 SHEET 6 H 6 ARG B 221 GLN B 224 -1 N ARG B 221 O TYR B 231 SHEET 1 I 2 THR B 182 VAL B 183 0 SHEET 2 I 2 ILE B 199 ILE B 200 1 O ILE B 200 N THR B 182 SHEET 1 J 3 LEU B 272 TYR B 277 0 SHEET 2 J 3 TYR B 298 TYR B 303 1 O VAL B 302 N LEU B 275 SHEET 3 J 3 LEU B 320 GLU B 324 1 O LYS B 322 N VAL B 301 LINK C ARG A 80 N MSE A 81 1555 1555 1.33 LINK C MSE A 81 N MSE A 82 1555 1555 1.33 LINK C MSE A 82 N ARG A 83 1555 1555 1.33 LINK C VAL A 116 N MSE A 117 1555 1555 1.33 LINK C MSE A 117 N SER A 118 1555 1555 1.33 LINK C PHE A 177 N MSE A 178 1555 1555 1.33 LINK C MSE A 178 N GLY A 179 1555 1555 1.33 LINK C LEU A 313 N MSE A 314 1555 1555 1.33 LINK C MSE A 314 N GLY A 315 1555 1555 1.33 LINK C ARG B 80 N MSE B 81 1555 1555 1.32 LINK C MSE B 81 N MSE B 82 1555 1555 1.33 LINK C MSE B 82 N ARG B 83 1555 1555 1.32 LINK C VAL B 116 N MSE B 117 1555 1555 1.33 LINK C MSE B 117 N SER B 118 1555 1555 1.33 LINK C PHE B 177 N MSE B 178 1555 1555 1.32 LINK C MSE B 178 N GLY B 179 1555 1555 1.33 LINK C LEU B 313 N MSE B 314 1555 1555 1.34 LINK C MSE B 314 N GLY B 315 1555 1555 1.32 CISPEP 1 GLN A 226 PRO A 227 0 -2.48 CISPEP 2 GLN B 226 PRO B 227 0 -4.95 CRYST1 47.598 113.414 80.951 90.00 101.77 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021009 0.000000 0.004377 0.00000 SCALE2 0.000000 0.008817 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012618 0.00000